$MOJO

Mojo Organics, Inc.

CIK:0001414953|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 1,259,453	$ 1,102,577	$ 2,220,937	$ 1,920,325
Cost of Sales	546,776	629,690	1,014,626	1,126,694
Gross Profit	712,677	472,887	1,206,311	793,631
Operating Expenses [Abstract]
Selling, general, and administrative	473,970	309,045	893,302	540,223
Total Operating Expenses	473,970	309,045	893,302	540,223
Income from Operations	238,707	163,842	313,009	253,408
Interest Expense	(4,966)	(7,981)	(11,327)	(11,973)
Other Income	4,972	0	117,264	0
Income Before Provision for Income Taxes	238,713	155,861	418,946	241,435
Income Tax Benefit (Expense) – Refer to Note 8	760,986	(2,805)	756,868	(4,345)
Net Income	$ 999,699	$ 153,056	$ 1,175,814	$ 237,090
Net Income Per Common Share, Diluted	$ 0.11	$ 0.02	$ 0.12	$ 0.03
Net Income Per Common Share, Basic	$ 0.11	$ 0.02	$ 0.12	$ 0.03
Weighted-Average Common Shares Outstanding, Diluted	9,464,160	9,095,063	9,452,487	9,102,151
Weighted-Average Common Shares Outstanding, Basic	9,464,160	9,095,063	9,452,487	9,102,151

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Net income	$ 1,175,814	$ 237,090
Adjustments to Reconcile Net Income to Net Cash Provided by (Used in) Operating Activities:
Restricted, non-trading common stock issued to directors and employees	88,200	840
Deferred income tax benefit	(765,997)
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Accounts and other receivables	(43,994)	(157,276)
Inventory	(441,247)	(650,086)
Supplier deposits	(96,211)	38,948
Prepaid expenses	10,864	(18,403)
Accounts payable and accrued expenses	128,506	285,796
Net Cash Provided by (Used in) Operating Activities	55,935	(263,091)
Net Cash Provided by (Used in) Financing Activities:
Shares repurchased for cancellation	(21,635)	(60,000)
Proceeds from Related Party Debt	68,000	384,000
Repayments of related party loan	(248,000)	(40,000)
Net Cash Provided by (Used in) Financing Activities	(201,635)	284,000
Net Increase (Decrease) in Cash and Cash Equivalents	(145,700)	20,909
Cash and Cash Equivalents at Beginning of Period	219,457	22,799
Cash and Cash Equivalents at End of Period	73,757	43,708
Supplemental Cash Flow Information [Abstract]
Interest Paid, Excluding Capitalized Interest, Operating Activity	11,327	11,973
Summary of non-cash investing and financing activity:
Restricted, non-trading common stock issued to directors and employees See Note 5 – Stock Transactions	88,200	0
Restricted Stock [Member]
Summary of non-cash investing and financing activity:
Restricted, non-trading common stock issued to directors and employees See Note 5 – Stock Transactions	$ 112,500	$ 840

Condensed Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash	$ 73,757	$ 219,457
Accounts and other receivables	393,816	349,822
Inventory	949,548	508,301
Supplier deposits	148,540	52,329
Prepaid expenses	50,273	61,137
Total Current Assets	1,615,934	1,191,046
Noncurrent Assets
Deferred tax assets, net	765,997
Total Noncurrent Assets	765,997
Total Assets	2,381,931	1,191,046
Current Liabilities
Accounts payable and accrued expenses	399,279	295,073
Related party loans	160,000	340,000
Total Current Liabilities	559,279	635,073
Total Liabilities	559,279	635,073
Stockholders' Equity
Common stock, $0.001 par value; 10,000,000 shares authorized; 9,509,655 and 9,380,260 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	9,510	9,381
Additional paid-in capital	25,198,498	25,107,762
Accumulated deficit	(23,385,356)	(24,561,170)
Total Stockholders' Equity	1,822,652	555,973
Total Liabilities and Stockholders' Equity	$ 2,381,931	$ 1,191,046